Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 116 | 2024 | 821 | 20.200 |
Why?
|
Glutens | 49 | 2022 | 240 | 9.820 |
Why?
|
Haptoglobins | 40 | 2024 | 165 | 7.600 |
Why?
|
Diet, Gluten-Free | 39 | 2022 | 285 | 6.420 |
Why?
|
Intestinal Mucosa | 61 | 2023 | 3043 | 5.950 |
Why?
|
Protein Precursors | 38 | 2024 | 1134 | 5.800 |
Why?
|
Cholera Toxin | 35 | 2020 | 562 | 4.840 |
Why?
|
Tight Junctions | 29 | 2023 | 324 | 4.040 |
Why?
|
Gliadin | 29 | 2023 | 80 | 3.800 |
Why?
|
Permeability | 39 | 2022 | 721 | 3.560 |
Why?
|
Duodenum | 14 | 2022 | 495 | 2.820 |
Why?
|
Transglutaminases | 19 | 2023 | 200 | 2.750 |
Why?
|
Oligopeptides | 12 | 2021 | 1195 | 2.150 |
Why?
|
Intestine, Small | 16 | 2019 | 1217 | 1.950 |
Why?
|
Probiotics | 8 | 2024 | 387 | 1.850 |
Why?
|
Autoimmune Diseases | 18 | 2021 | 2255 | 1.840 |
Why?
|
Intestinal Diseases | 6 | 2024 | 505 | 1.650 |
Why?
|
Intestines | 19 | 2023 | 1905 | 1.570 |
Why?
|
Intestinal Absorption | 11 | 2019 | 400 | 1.490 |
Why?
|
Gastrointestinal Tract | 12 | 2022 | 837 | 1.490 |
Why?
|
Immunoglobulin A | 19 | 2024 | 992 | 1.480 |
Why?
|
Gastrointestinal Diseases | 8 | 2021 | 1205 | 1.280 |
Why?
|
Autoimmunity | 10 | 2021 | 1361 | 1.240 |
Why?
|
Systemic Inflammatory Response Syndrome | 9 | 2024 | 621 | 1.200 |
Why?
|
Food Hypersensitivity | 7 | 2020 | 734 | 1.160 |
Why?
|
Irritable Bowel Syndrome | 7 | 2020 | 454 | 1.110 |
Why?
|
Salmonella typhi | 6 | 2024 | 200 | 1.060 |
Why?
|
Autoantibodies | 18 | 2023 | 2114 | 0.990 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2024 | 2441 | 0.990 |
Why?
|
Colostrum | 1 | 2023 | 28 | 0.880 |
Why?
|
Inflammation | 22 | 2023 | 10869 | 0.840 |
Why?
|
Humans | 250 | 2024 | 767040 | 0.840 |
Why?
|
Blood-Brain Barrier | 6 | 2022 | 1029 | 0.830 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.830 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2016 | 328 | 0.800 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2023 | 3449 | 0.790 |
Why?
|
Typhoid Fever | 5 | 2024 | 195 | 0.790 |
Why?
|
Shigella flexneri | 4 | 2019 | 118 | 0.790 |
Why?
|
Serologic Tests | 8 | 2019 | 382 | 0.790 |
Why?
|
GTP-Binding Proteins | 4 | 2017 | 946 | 0.780 |
Why?
|
Diet | 10 | 2024 | 8089 | 0.760 |
Why?
|
Cytokines | 19 | 2024 | 7446 | 0.750 |
Why?
|
Gastrointestinal Transit | 1 | 2021 | 102 | 0.720 |
Why?
|
HLA Antigens | 6 | 2019 | 1334 | 0.720 |
Why?
|
Gastric Emptying | 2 | 2021 | 247 | 0.690 |
Why?
|
HLA-DQ Antigens | 9 | 2020 | 190 | 0.690 |
Why?
|
Child | 70 | 2024 | 80771 | 0.670 |
Why?
|
Addison Disease | 1 | 2020 | 48 | 0.660 |
Why?
|
Dermatitis Herpetiformis | 5 | 2014 | 22 | 0.640 |
Why?
|
Intercellular Junctions | 1 | 2019 | 198 | 0.620 |
Why?
|
Metagenome | 2 | 2013 | 464 | 0.620 |
Why?
|
Metabolome | 7 | 2023 | 1008 | 0.620 |
Why?
|
Receptors, CXCR3 | 2 | 2010 | 240 | 0.610 |
Why?
|
Caco-2 Cells | 12 | 2022 | 364 | 0.600 |
Why?
|
Cell Membrane Permeability | 4 | 2011 | 568 | 0.600 |
Why?
|
Wheat Hypersensitivity | 3 | 2018 | 11 | 0.580 |
Why?
|
Biopsy | 15 | 2022 | 6777 | 0.560 |
Why?
|
Immunity, Mucosal | 6 | 2024 | 499 | 0.560 |
Why?
|
Infant | 37 | 2024 | 36485 | 0.550 |
Why?
|
Breast Feeding | 5 | 2019 | 1362 | 0.550 |
Why?
|
Peptides | 5 | 2021 | 4348 | 0.550 |
Why?
|
Interleukin-8 | 5 | 2019 | 704 | 0.550 |
Why?
|
Immunoglobulin G | 17 | 2024 | 4560 | 0.540 |
Why?
|
Vomiting | 1 | 2020 | 655 | 0.530 |
Why?
|
Hypersensitivity | 3 | 2016 | 1169 | 0.530 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 2020 | 347 | 0.520 |
Why?
|
Milk, Human | 4 | 2024 | 490 | 0.520 |
Why?
|
Diarrhea | 11 | 2020 | 1319 | 0.500 |
Why?
|
Antibodies, Viral | 10 | 2024 | 3212 | 0.490 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2015 | 163 | 0.490 |
Why?
|
Animals | 68 | 2023 | 168965 | 0.490 |
Why?
|
Receptors, Formyl Peptide | 1 | 2015 | 146 | 0.480 |
Why?
|
Metabolomics | 7 | 2022 | 1675 | 0.480 |
Why?
|
Antibodies | 9 | 2019 | 2419 | 0.470 |
Why?
|
Chickens | 1 | 2016 | 843 | 0.470 |
Why?
|
Schizophrenia | 11 | 2020 | 6977 | 0.460 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 511 | 0.460 |
Why?
|
Shigella dysenteriae | 1 | 2014 | 14 | 0.460 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1477 | 0.450 |
Why?
|
Epithelial Cells | 11 | 2021 | 3698 | 0.450 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2016 | 238 | 0.450 |
Why?
|
Lactobacillus | 2 | 2019 | 212 | 0.440 |
Why?
|
Interleukin-10 | 2 | 2020 | 1182 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 15 | 2024 | 18063 | 0.440 |
Why?
|
Automation, Laboratory | 1 | 2014 | 102 | 0.440 |
Why?
|
Receptor, PAR-2 | 2 | 2010 | 33 | 0.440 |
Why?
|
Antiviral Agents | 4 | 2023 | 3070 | 0.430 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2016 | 340 | 0.430 |
Why?
|
Food Contamination | 2 | 2013 | 193 | 0.430 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2024 | 2183 | 0.420 |
Why?
|
Bacteria | 6 | 2020 | 2212 | 0.420 |
Why?
|
Feeding Methods | 2 | 2017 | 35 | 0.420 |
Why?
|
Abdominal Pain | 2 | 2018 | 1069 | 0.410 |
Why?
|
Child, Preschool | 35 | 2024 | 42606 | 0.410 |
Why?
|
Infant, Newborn | 25 | 2024 | 26396 | 0.400 |
Why?
|
Malabsorption Syndromes | 3 | 2018 | 135 | 0.390 |
Why?
|
Food | 3 | 2020 | 766 | 0.390 |
Why?
|
Hospitals, General | 1 | 2016 | 804 | 0.390 |
Why?
|
Enterobacteriaceae | 3 | 2021 | 161 | 0.390 |
Why?
|
Down-Regulation | 2 | 2017 | 2931 | 0.390 |
Why?
|
Female | 96 | 2024 | 396660 | 0.380 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 888 | 0.380 |
Why?
|
Peptide Hydrolases | 3 | 2018 | 610 | 0.370 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.370 |
Why?
|
Hedgehog Proteins | 1 | 2015 | 771 | 0.360 |
Why?
|
Hypersensitivity, Delayed | 1 | 2012 | 491 | 0.360 |
Why?
|
Colitis | 2 | 2017 | 1238 | 0.360 |
Why?
|
Immunity | 6 | 2024 | 1002 | 0.360 |
Why?
|
Male | 88 | 2024 | 364203 | 0.350 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2017 | 352 | 0.350 |
Why?
|
Immunoassay | 1 | 2014 | 744 | 0.350 |
Why?
|
Autistic Disorder | 2 | 2017 | 1239 | 0.340 |
Why?
|
Case-Control Studies | 18 | 2022 | 22254 | 0.340 |
Why?
|
Critical Illness | 2 | 2022 | 2753 | 0.340 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1794 | 0.330 |
Why?
|
Stomach | 2 | 2018 | 701 | 0.330 |
Why?
|
Allergens | 2 | 2015 | 1436 | 0.330 |
Why?
|
Metagenomics | 4 | 2021 | 473 | 0.330 |
Why?
|
Child Development | 5 | 2018 | 2329 | 0.330 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1626 | 0.330 |
Why?
|
Obesity | 4 | 2023 | 13085 | 0.330 |
Why?
|
Immunity, Innate | 6 | 2019 | 3076 | 0.320 |
Why?
|
Helicobacter pylori | 1 | 2013 | 380 | 0.320 |
Why?
|
Cerebellum | 1 | 2016 | 1521 | 0.320 |
Why?
|
Adolescent | 35 | 2023 | 89046 | 0.320 |
Why?
|
Thyroid Nodule | 1 | 2016 | 765 | 0.320 |
Why?
|
Myosins | 1 | 2010 | 406 | 0.320 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1466 | 0.310 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 12986 | 0.300 |
Why?
|
Interferon-gamma | 1 | 2017 | 3154 | 0.300 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2023 | 1044 | 0.300 |
Why?
|
Neutrophils | 3 | 2022 | 3779 | 0.300 |
Why?
|
Interleukin-17 | 3 | 2019 | 922 | 0.300 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2013 | 597 | 0.300 |
Why?
|
Triticum | 4 | 2018 | 92 | 0.300 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 521 | 0.290 |
Why?
|
Antibody Formation | 2 | 2022 | 1392 | 0.290 |
Why?
|
Mice, Transgenic | 7 | 2023 | 9551 | 0.290 |
Why?
|
Sepsis | 1 | 2021 | 2605 | 0.290 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2824 | 0.280 |
Why?
|
Pituitary Gland | 1 | 2010 | 635 | 0.280 |
Why?
|
Endothelial Cells | 3 | 2016 | 3582 | 0.270 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8535 | 0.270 |
Why?
|
Fatty Liver | 1 | 2013 | 811 | 0.270 |
Why?
|
Young Adult | 24 | 2023 | 59980 | 0.270 |
Why?
|
Leukocytes, Mononuclear | 5 | 2024 | 1854 | 0.270 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2005 | 29 | 0.260 |
Why?
|
Environment | 3 | 2020 | 1120 | 0.260 |
Why?
|
Patient Compliance | 3 | 2013 | 2697 | 0.260 |
Why?
|
Mice, Inbred C57BL | 16 | 2023 | 22361 | 0.260 |
Why?
|
Phosphoproteins | 4 | 2020 | 2448 | 0.250 |
Why?
|
Specimen Handling | 2 | 2020 | 706 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2299 | 0.250 |
Why?
|
Pregnancy | 15 | 2024 | 30238 | 0.250 |
Why?
|
Myocarditis | 2 | 2023 | 802 | 0.250 |
Why?
|
Feeding Behavior | 2 | 2015 | 3207 | 0.250 |
Why?
|
Lipopolysaccharides | 6 | 2021 | 2217 | 0.240 |
Why?
|
Bacterial Translocation | 3 | 2020 | 74 | 0.240 |
Why?
|
Mice | 30 | 2023 | 81912 | 0.240 |
Why?
|
Feces | 7 | 2022 | 1508 | 0.240 |
Why?
|
Endotoxins | 11 | 2010 | 519 | 0.240 |
Why?
|
Escherichia coli | 4 | 2019 | 4209 | 0.240 |
Why?
|
Psychotic Disorders | 5 | 2019 | 3275 | 0.240 |
Why?
|
Cell Movement | 2 | 2019 | 5203 | 0.230 |
Why?
|
Adult | 45 | 2024 | 223317 | 0.230 |
Why?
|
Wound Healing | 1 | 2015 | 2800 | 0.230 |
Why?
|
Adaptive Immunity | 3 | 2021 | 733 | 0.230 |
Why?
|
Dysentery, Bacillary | 2 | 2016 | 73 | 0.230 |
Why?
|
Organoids | 2 | 2021 | 740 | 0.220 |
Why?
|
Genetic Testing | 3 | 2014 | 3591 | 0.220 |
Why?
|
Shigella Vaccines | 2 | 2014 | 10 | 0.220 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2023 | 105 | 0.220 |
Why?
|
Nutrition Assessment | 2 | 2024 | 740 | 0.220 |
Why?
|
Body Height | 1 | 2010 | 1565 | 0.220 |
Why?
|
Environmental Exposure | 2 | 2024 | 4546 | 0.220 |
Why?
|
Biological Warfare | 1 | 2003 | 24 | 0.220 |
Why?
|
Viral Load | 3 | 2021 | 3385 | 0.210 |
Why?
|
Organ Culture Techniques | 5 | 2019 | 789 | 0.210 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3828 | 0.210 |
Why?
|
Toll-Like Receptor 4 | 5 | 2020 | 588 | 0.210 |
Why?
|
Claudins | 3 | 2016 | 116 | 0.210 |
Why?
|
Receptor, Cannabinoid, CB2 | 2 | 2013 | 48 | 0.210 |
Why?
|
Anti-Bacterial Agents | 6 | 2024 | 7469 | 0.210 |
Why?
|
Budesonide | 2 | 2022 | 162 | 0.210 |
Why?
|
Helminths | 1 | 2023 | 39 | 0.210 |
Why?
|
Synbiotics | 1 | 2022 | 12 | 0.210 |
Why?
|
Comorbidity | 9 | 2024 | 10582 | 0.210 |
Why?
|
Haplotypes | 5 | 2020 | 2722 | 0.200 |
Why?
|
Risk Factors | 17 | 2020 | 74886 | 0.200 |
Why?
|
Bacteroides | 2 | 2020 | 165 | 0.200 |
Why?
|
Prospective Studies | 20 | 2023 | 54886 | 0.200 |
Why?
|
Mass Screening | 3 | 2009 | 5456 | 0.200 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.200 |
Why?
|
Helminthiasis | 1 | 2023 | 81 | 0.200 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15424 | 0.200 |
Why?
|
Bacterial Toxins | 2 | 2005 | 922 | 0.200 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 13411 | 0.190 |
Why?
|
Terminology as Topic | 3 | 2015 | 1540 | 0.190 |
Why?
|
Bifidobacterium | 2 | 2019 | 99 | 0.190 |
Why?
|
Osteoporosis | 2 | 2012 | 1604 | 0.190 |
Why?
|
Prevalence | 11 | 2019 | 15851 | 0.190 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2018 | 40 | 0.190 |
Why?
|
Nasopharynx | 1 | 2024 | 419 | 0.190 |
Why?
|
Vero Cells | 1 | 2022 | 486 | 0.190 |
Why?
|
Anorexia Nervosa | 2 | 2021 | 1363 | 0.190 |
Why?
|
Gastric Mucosa | 2 | 2021 | 602 | 0.180 |
Why?
|
Cell Line | 8 | 2021 | 15567 | 0.180 |
Why?
|
Viral Nonstructural Proteins | 1 | 2022 | 228 | 0.180 |
Why?
|
Blood Cells | 1 | 2023 | 309 | 0.180 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.180 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11923 | 0.180 |
Why?
|
Interleukin-1beta | 5 | 2019 | 1027 | 0.180 |
Why?
|
Radiation Injuries, Experimental | 2 | 2016 | 88 | 0.180 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 154 | 0.180 |
Why?
|
Membrane Proteins | 7 | 2017 | 7868 | 0.180 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 159 | 0.180 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5754 | 0.180 |
Why?
|
Kynurenic Acid | 1 | 2020 | 44 | 0.170 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17608 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Viral Matrix Proteins | 1 | 2021 | 193 | 0.170 |
Why?
|
Pilot Projects | 8 | 2021 | 8732 | 0.170 |
Why?
|
Immunologic Tests | 1 | 2020 | 101 | 0.170 |
Why?
|
Salmonella paratyphi B | 1 | 2019 | 2 | 0.170 |
Why?
|
Saliva | 1 | 2024 | 853 | 0.170 |
Why?
|
Diarrhea, Infantile | 2 | 2019 | 100 | 0.170 |
Why?
|
Longitudinal Studies | 7 | 2021 | 14766 | 0.170 |
Why?
|
Monocytes | 6 | 2022 | 2598 | 0.170 |
Why?
|
Bacterial Adhesion | 2 | 2019 | 306 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 454 | 0.170 |
Why?
|
Chromosome Disorders | 1 | 2022 | 498 | 0.170 |
Why?
|
Stem Cells | 4 | 2019 | 3535 | 0.160 |
Why?
|
Salmonella paratyphi A | 1 | 2019 | 47 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2023 | 11657 | 0.160 |
Why?
|
Gastroenterology | 4 | 2016 | 593 | 0.160 |
Why?
|
Growth Disorders | 1 | 2004 | 635 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
Pancrelipase | 1 | 2018 | 7 | 0.160 |
Why?
|
Enterobacteriaceae Infections | 1 | 2021 | 190 | 0.160 |
Why?
|
Drug Repositioning | 1 | 2021 | 246 | 0.160 |
Why?
|
Flagellin | 1 | 2019 | 124 | 0.160 |
Why?
|
Treatment Failure | 2 | 2017 | 2658 | 0.160 |
Why?
|
Catalytic Domain | 1 | 2021 | 699 | 0.160 |
Why?
|
Lactococcus lactis | 1 | 2018 | 28 | 0.160 |
Why?
|
Protease Inhibitors | 1 | 2022 | 750 | 0.160 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1040 | 0.160 |
Why?
|
Serine Endopeptidases | 3 | 2020 | 1027 | 0.160 |
Why?
|
Cattle | 2 | 2023 | 3813 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 426 | 0.150 |
Why?
|
Signal Transduction | 11 | 2020 | 23621 | 0.150 |
Why?
|
Dextran Sulfate | 2 | 2017 | 256 | 0.150 |
Why?
|
Salmonella Infections | 1 | 2019 | 173 | 0.150 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2018 | 46 | 0.150 |
Why?
|
Rats | 14 | 2017 | 23713 | 0.150 |
Why?
|
Tryptophan | 1 | 2020 | 484 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 632 | 0.150 |
Why?
|
Gastroparesis | 1 | 2020 | 143 | 0.150 |
Why?
|
Weightlessness | 2 | 2016 | 103 | 0.150 |
Why?
|
Bone Marrow | 2 | 2020 | 2926 | 0.150 |
Why?
|
Disease Management | 2 | 2020 | 2531 | 0.150 |
Why?
|
Eating | 1 | 2024 | 1541 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 223233 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.150 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1085 | 0.140 |
Why?
|
Placenta | 3 | 2022 | 1726 | 0.140 |
Why?
|
Iron Overload | 1 | 2020 | 245 | 0.140 |
Why?
|
Genomics | 4 | 2023 | 5924 | 0.140 |
Why?
|
RNA, Messenger | 9 | 2024 | 12793 | 0.140 |
Why?
|
Bioreactors | 2 | 2016 | 245 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 812 | 0.140 |
Why?
|
Capsule Endoscopy | 1 | 2018 | 106 | 0.140 |
Why?
|
Liver | 1 | 2013 | 7578 | 0.140 |
Why?
|
Massachusetts | 3 | 2020 | 8890 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 381 | 0.140 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2019 | 1137 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.140 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2018 | 45 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 994 | 0.140 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15925 | 0.140 |
Why?
|
Microvilli | 3 | 2013 | 235 | 0.140 |
Why?
|
Incidence | 6 | 2022 | 21526 | 0.140 |
Why?
|
Ileitis | 1 | 2017 | 40 | 0.140 |
Why?
|
HMGA1a Protein | 1 | 2017 | 63 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1354 | 0.140 |
Why?
|
Cytomegalovirus | 1 | 2021 | 751 | 0.140 |
Why?
|
Double-Blind Method | 6 | 2022 | 12451 | 0.140 |
Why?
|
Vaccines, Attenuated | 2 | 2018 | 314 | 0.140 |
Why?
|
Paneth Cells | 1 | 2017 | 100 | 0.140 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26325 | 0.130 |
Why?
|
Major Histocompatibility Complex | 1 | 2019 | 879 | 0.130 |
Why?
|
Stress, Psychological | 2 | 2023 | 4526 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12790 | 0.130 |
Why?
|
Peptide Fragments | 6 | 2015 | 5141 | 0.130 |
Why?
|
Immunologic Factors | 3 | 2018 | 1592 | 0.130 |
Why?
|
Age Factors | 5 | 2020 | 18401 | 0.130 |
Why?
|
Models, Immunological | 1 | 2018 | 516 | 0.130 |
Why?
|
Polysaccharides, Bacterial | 1 | 2018 | 582 | 0.130 |
Why?
|
Up-Regulation | 4 | 2017 | 4143 | 0.130 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 306 | 0.120 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1442 | 0.120 |
Why?
|
Models, Biological | 4 | 2014 | 9464 | 0.120 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2015 | 221 | 0.120 |
Why?
|
Endoscopy, Digestive System | 2 | 2018 | 358 | 0.120 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 435 | 0.120 |
Why?
|
Spondylitis, Ankylosing | 1 | 2017 | 158 | 0.120 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1271 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2012 | 7435 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14672 | 0.120 |
Why?
|
Chemotactic Factors | 1 | 2015 | 197 | 0.120 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18330 | 0.120 |
Why?
|
Phenotype | 6 | 2023 | 16718 | 0.120 |
Why?
|
Cells, Cultured | 10 | 2019 | 18989 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2212 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1362 | 0.120 |
Why?
|
Anemia | 2 | 2015 | 1514 | 0.120 |
Why?
|
Th17 Cells | 2 | 2021 | 790 | 0.120 |
Why?
|
Duodenal Diseases | 1 | 2015 | 101 | 0.120 |
Why?
|
Vaccination | 6 | 2024 | 3434 | 0.110 |
Why?
|
Endothelium | 1 | 2017 | 768 | 0.110 |
Why?
|
Gene Expression | 4 | 2019 | 7587 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 409 | 0.110 |
Why?
|
Cohort Studies | 8 | 2023 | 41718 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1029 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2015 | 121 | 0.110 |
Why?
|
Body Weight | 3 | 2017 | 4627 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1361 | 0.110 |
Why?
|
Macrophages | 3 | 2023 | 5785 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1646 | 0.110 |
Why?
|
Receptors, Steroid | 1 | 2014 | 157 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2021 | 1865 | 0.110 |
Why?
|
Enterocytes | 2 | 2021 | 220 | 0.110 |
Why?
|
Pediatrics | 3 | 2019 | 3621 | 0.110 |
Why?
|
Histocompatibility Testing | 2 | 2007 | 717 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3804 | 0.110 |
Why?
|
Colony Count, Microbial | 1 | 2014 | 325 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 633 | 0.110 |
Why?
|
Electric Impedance | 3 | 2013 | 792 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2015 | 393 | 0.100 |
Why?
|
Aged | 16 | 2024 | 171319 | 0.100 |
Why?
|
Drug Discovery | 1 | 2021 | 1068 | 0.100 |
Why?
|
Binding Sites | 1 | 2021 | 6014 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3112 | 0.100 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2013 | 137 | 0.100 |
Why?
|
Ileum | 4 | 2017 | 558 | 0.100 |
Why?
|
Sex Distribution | 2 | 2016 | 2276 | 0.100 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2015 | 661 | 0.100 |
Why?
|
Asia | 1 | 2014 | 629 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3234 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 454 | 0.100 |
Why?
|
Radiation Protection | 1 | 2016 | 428 | 0.100 |
Why?
|
Jejunum | 2 | 2012 | 474 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2024 | 65295 | 0.100 |
Why?
|
Cell Communication | 1 | 2019 | 1660 | 0.100 |
Why?
|
Switzerland | 3 | 2018 | 322 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10748 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2020 | 2745 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1716 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1083 | 0.100 |
Why?
|
Infant Food | 1 | 2012 | 139 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2022 | 4925 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 4054 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10254 | 0.090 |
Why?
|
Immune Tolerance | 2 | 2016 | 2322 | 0.090 |
Why?
|
Brain | 2 | 2017 | 27163 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1130 | 0.090 |
Why?
|
Lymphocytes | 4 | 2019 | 2605 | 0.090 |
Why?
|
Antigens, Plant | 1 | 2011 | 104 | 0.090 |
Why?
|
Postmenopause | 1 | 2020 | 2518 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1444 | 0.090 |
Why?
|
Leukocytes | 1 | 2019 | 2034 | 0.090 |
Why?
|
Enterotoxins | 1 | 2012 | 366 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20169 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1381 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.090 |
Why?
|
Weight Loss | 2 | 2020 | 2716 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1804 | 0.090 |
Why?
|
Pandemics | 5 | 2021 | 8736 | 0.090 |
Why?
|
Bioengineering | 1 | 2011 | 99 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2015 | 845 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2010 | 113 | 0.090 |
Why?
|
Primary Health Care | 1 | 2007 | 4746 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2227 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2016 | 684 | 0.090 |
Why?
|
Regeneration | 2 | 2016 | 1523 | 0.090 |
Why?
|
Weight Gain | 1 | 2020 | 2360 | 0.090 |
Why?
|
Immune System Diseases | 1 | 2012 | 253 | 0.090 |
Why?
|
Cholestasis | 1 | 2013 | 385 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2013 | 738 | 0.080 |
Why?
|
Hordeum | 1 | 2009 | 18 | 0.080 |
Why?
|
Threonine | 1 | 2010 | 272 | 0.080 |
Why?
|
Public Health | 1 | 2003 | 2681 | 0.080 |
Why?
|
Atrophy | 2 | 2013 | 1631 | 0.080 |
Why?
|
Lactation | 2 | 2022 | 392 | 0.080 |
Why?
|
Receptors, CCR6 | 1 | 2009 | 73 | 0.080 |
Why?
|
Age of Onset | 3 | 2021 | 3344 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 599 | 0.080 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2008 | 582 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 377 | 0.080 |
Why?
|
Dietary Proteins | 1 | 2014 | 960 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6513 | 0.080 |
Why?
|
Immunoblotting | 2 | 2010 | 1647 | 0.080 |
Why?
|
Caspases | 1 | 2012 | 881 | 0.080 |
Why?
|
Interleukin-15 | 1 | 2010 | 186 | 0.080 |
Why?
|
Sweden | 1 | 2012 | 1382 | 0.080 |
Why?
|
Phylogeny | 2 | 2018 | 2840 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 411 | 0.080 |
Why?
|
Alleles | 1 | 2020 | 6893 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1982 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2105 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2012 | 950 | 0.080 |
Why?
|
Italy | 3 | 2019 | 856 | 0.080 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2009 | 355 | 0.080 |
Why?
|
Acute Disease | 4 | 2023 | 7236 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1655 | 0.080 |
Why?
|
Time Factors | 5 | 2022 | 40154 | 0.080 |
Why?
|
Rats, Wistar | 2 | 2010 | 1885 | 0.080 |
Why?
|
Nutritional Support | 1 | 2020 | 178 | 0.080 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 360 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2022 | 81659 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2019 | 10455 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59548 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3272 | 0.070 |
Why?
|
Antigens | 1 | 2013 | 1442 | 0.070 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2007 | 18 | 0.070 |
Why?
|
Genetic Loci | 2 | 2014 | 2629 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2007 | 152 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2009 | 354 | 0.070 |
Why?
|
Europe | 1 | 2014 | 3432 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9362 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39317 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 3114 | 0.070 |
Why?
|
Adjuvants, Immunologic | 2 | 2003 | 998 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3834 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2010 | 6226 | 0.070 |
Why?
|
Cell Survival | 3 | 2014 | 5750 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2008 | 202 | 0.070 |
Why?
|
Age Distribution | 2 | 2010 | 2870 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1083 | 0.070 |
Why?
|
Eosinophilic Esophagitis | 1 | 2020 | 205 | 0.070 |
Why?
|
Serine | 1 | 2010 | 828 | 0.070 |
Why?
|
Algorithms | 4 | 2014 | 14098 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 983 | 0.060 |
Why?
|
ROC Curve | 1 | 2014 | 3618 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.060 |
Why?
|
RNA Interference | 2 | 2014 | 2829 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.060 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1889 | 0.060 |
Why?
|
Nutritional Status | 2 | 2024 | 1628 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3778 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1531 | 0.060 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 539 | 0.060 |
Why?
|
Rats, Inbred BB | 1 | 2005 | 29 | 0.060 |
Why?
|
United States | 7 | 2022 | 72971 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29963 | 0.060 |
Why?
|
Societies, Medical | 4 | 2013 | 3964 | 0.060 |
Why?
|
Adherens Junctions | 2 | 2017 | 90 | 0.060 |
Why?
|
Constipation | 2 | 2022 | 570 | 0.060 |
Why?
|
Fibroblasts | 2 | 2016 | 4167 | 0.060 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2004 | 294 | 0.060 |
Why?
|
Lactoferrin | 1 | 2005 | 100 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2954 | 0.060 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1477 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 349 | 0.060 |
Why?
|
Th1 Cells | 1 | 2010 | 1040 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1751 | 0.060 |
Why?
|
Cyclosporine | 1 | 2007 | 778 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1660 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2008 | 1252 | 0.060 |
Why?
|
Biological Availability | 4 | 2007 | 387 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2007 | 793 | 0.060 |
Why?
|
Anorexia | 1 | 2005 | 153 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1188 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2021 | 5311 | 0.060 |
Why?
|
Dietary Supplements | 2 | 2024 | 3446 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2006 | 344 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2022 | 2353 | 0.060 |
Why?
|
Fluid Therapy | 2 | 2005 | 587 | 0.060 |
Why?
|
Nose | 1 | 2007 | 522 | 0.060 |
Why?
|
Mental Disorders | 2 | 2015 | 6873 | 0.060 |
Why?
|
Acyclovir | 1 | 2004 | 267 | 0.050 |
Why?
|
RNA, Viral | 2 | 2023 | 2867 | 0.050 |
Why?
|
Microscopy, Fluorescence | 2 | 2012 | 2628 | 0.050 |
Why?
|
North America | 1 | 2007 | 1287 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2016 | 3618 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1389 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 10393 | 0.050 |
Why?
|
Mitoxantrone | 1 | 2022 | 148 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2592 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 188 | 0.050 |
Why?
|
Anthrax | 1 | 2003 | 83 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 7 | 2007 | 8108 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 834 | 0.050 |
Why?
|
Mannitol | 1 | 2003 | 176 | 0.050 |
Why?
|
Gallbladder | 1 | 2024 | 308 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 100 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9746 | 0.050 |
Why?
|
Vaccines, Synthetic | 1 | 2024 | 621 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3684 | 0.050 |
Why?
|
Finland | 1 | 2003 | 608 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6507 | 0.050 |
Why?
|
Salmonella | 1 | 2022 | 125 | 0.050 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2002 | 120 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 4349 | 0.050 |
Why?
|
Gangliosides | 1 | 2002 | 132 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2004 | 1430 | 0.050 |
Why?
|
Escherichia coli Infections | 1 | 2005 | 518 | 0.050 |
Why?
|
Digestive System | 1 | 2002 | 244 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2008 | 2093 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2017 | 6215 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2009 | 1429 | 0.050 |
Why?
|
Bone Development | 1 | 2004 | 473 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6067 | 0.050 |
Why?
|
Drug Carriers | 1 | 2005 | 702 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3324 | 0.050 |
Why?
|
Mucus | 1 | 2023 | 346 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.050 |
Why?
|
Neoplasms | 3 | 2022 | 22350 | 0.040 |
Why?
|
Methane | 1 | 2020 | 44 | 0.040 |
Why?
|
Thioctic Acid | 1 | 2020 | 28 | 0.040 |
Why?
|
Genotype | 3 | 2014 | 13035 | 0.040 |
Why?
|
Blotting, Western | 3 | 2012 | 5022 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4859 | 0.040 |
Why?
|
Transfection | 1 | 2008 | 5753 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2024 | 4405 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
Bangladesh | 1 | 2022 | 742 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2020 | 998 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13650 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2022 | 4280 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 553 | 0.040 |
Why?
|
Mucins | 1 | 2023 | 569 | 0.040 |
Why?
|
Arginase | 1 | 2020 | 81 | 0.040 |
Why?
|
Immobilization | 1 | 2020 | 229 | 0.040 |
Why?
|
Cadherins | 2 | 2017 | 903 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2538 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 610 | 0.040 |
Why?
|
Endoscopy | 1 | 2009 | 1854 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1924 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8310 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9612 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13284 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 3431 | 0.040 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1527 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2902 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 16036 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 537 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 187 | 0.040 |
Why?
|
Crohn Disease | 1 | 2011 | 2295 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2005 | 1055 | 0.040 |
Why?
|
Administration, Intranasal | 3 | 2007 | 483 | 0.040 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1278 | 0.040 |
Why?
|
Virulence Factors | 2 | 2016 | 498 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 271 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 546 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3913 | 0.040 |
Why?
|
Protein Binding | 1 | 2010 | 9327 | 0.040 |
Why?
|
Symbiosis | 1 | 2020 | 297 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5098 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 244 | 0.040 |
Why?
|
Disease Progression | 2 | 2023 | 13646 | 0.040 |
Why?
|
Macaca mulatta | 3 | 2016 | 2345 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13485 | 0.040 |
Why?
|
Desulfovibrio | 1 | 2017 | 7 | 0.040 |
Why?
|
Rhamnose | 1 | 2017 | 18 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2019 | 348 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1294 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3724 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 583 | 0.040 |
Why?
|
Administration, Oral | 4 | 2007 | 4026 | 0.030 |
Why?
|
Folic Acid | 1 | 2024 | 1336 | 0.030 |
Why?
|
Carrier State | 1 | 2021 | 529 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2017 | 70 | 0.030 |
Why?
|
Rabbits | 3 | 2012 | 4751 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 455 | 0.030 |
Why?
|
Health Policy | 1 | 2009 | 2698 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2017 | 66 | 0.030 |
Why?
|
Lactose | 1 | 2017 | 95 | 0.030 |
Why?
|
Prevotella | 1 | 2017 | 81 | 0.030 |
Why?
|
Vaccines | 1 | 2005 | 842 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15645 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 2 | 2011 | 348 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 800 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2021 | 707 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1606 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7871 | 0.030 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 145 | 0.030 |
Why?
|
Avitaminosis | 1 | 2016 | 35 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2131 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5537 | 0.030 |
Why?
|
Diet Surveys | 1 | 2020 | 1160 | 0.030 |
Why?
|
Biological Transport | 3 | 2007 | 2084 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2002 | 716 | 0.030 |
Why?
|
Absorption | 2 | 2007 | 243 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Phospholipids | 1 | 2019 | 778 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1776 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2017 | 251 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2602 | 0.030 |
Why?
|
Infant Formula | 1 | 2017 | 193 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2024 | 2429 | 0.030 |
Why?
|
Vasculitis | 1 | 2019 | 526 | 0.030 |
Why?
|
Family | 1 | 2006 | 3210 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 292 | 0.030 |
Why?
|
Family Health | 2 | 2012 | 1254 | 0.030 |
Why?
|
Fetal Development | 1 | 2020 | 777 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9532 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3834 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4572 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4210 | 0.030 |
Why?
|
Americas | 1 | 2014 | 110 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8048 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2020 | 802 | 0.030 |
Why?
|
Indomethacin | 1 | 2014 | 323 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1409 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2125 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2017 | 347 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4032 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3073 | 0.030 |
Why?
|
Risk Assessment | 3 | 2012 | 24299 | 0.030 |
Why?
|
Bacteriophages | 1 | 2017 | 382 | 0.030 |
Why?
|
Colitis, Microscopic | 1 | 2014 | 72 | 0.030 |
Why?
|
Mice, Inbred A | 1 | 2013 | 245 | 0.030 |
Why?
|
Bread | 1 | 2012 | 23 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7210 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3427 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 837 | 0.030 |
Why?
|
Flour | 1 | 2012 | 22 | 0.030 |
Why?
|
Congo Red | 1 | 2012 | 49 | 0.030 |
Why?
|
Movement | 1 | 2019 | 1473 | 0.030 |
Why?
|
Shigella | 1 | 2013 | 69 | 0.030 |
Why?
|
Area Under Curve | 2 | 2007 | 1639 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.020 |
Why?
|
Esophagus | 1 | 2018 | 1041 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4855 | 0.020 |
Why?
|
Drug Interactions | 2 | 2007 | 1419 | 0.020 |
Why?
|
Body Mass Index | 1 | 2010 | 13048 | 0.020 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2011 | 12 | 0.020 |
Why?
|
Reference Values | 2 | 2012 | 4918 | 0.020 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 372 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12069 | 0.020 |
Why?
|
Cesarean Section | 1 | 2020 | 1419 | 0.020 |
Why?
|
Spain | 1 | 2012 | 483 | 0.020 |
Why?
|
Norway | 1 | 2012 | 500 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2268 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9606 | 0.020 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2011 | 108 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2013 | 512 | 0.020 |
Why?
|
Integrin alpha Chains | 1 | 2011 | 93 | 0.020 |
Why?
|
Complement Activation | 1 | 2013 | 447 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2020 | 1495 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2011 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4424 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 645 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3599 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2056 | 0.020 |
Why?
|
Germany | 1 | 2012 | 882 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 412 | 0.020 |
Why?
|
Schools | 1 | 2019 | 1498 | 0.020 |
Why?
|
Trans-Activators | 1 | 2020 | 2856 | 0.020 |
Why?
|
DNA, Viral | 1 | 2017 | 2201 | 0.020 |
Why?
|
Ataxia | 1 | 2012 | 307 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 630 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 588 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2013 | 697 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1697 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4256 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2827 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5875 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1574 | 0.020 |
Why?
|
Inulin | 1 | 2007 | 67 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3931 | 0.020 |
Why?
|
Collagen Type I | 1 | 2011 | 617 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3618 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1168 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5332 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2014 | 1043 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4522 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2008 | 244 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2008 | 243 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1996 | 0.020 |
Why?
|
Biomedical Research | 2 | 2013 | 3464 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1496 | 0.020 |
Why?
|
Trachea | 1 | 2013 | 1095 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 273 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2008 | 301 | 0.020 |
Why?
|
HLA-D Antigens | 1 | 2006 | 130 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2765 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1836 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 17097 | 0.020 |
Why?
|
Agglutination Tests | 1 | 2005 | 43 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3702 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2586 | 0.020 |
Why?
|
Developing Countries | 2 | 2013 | 2911 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2008 | 855 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5499 | 0.020 |
Why?
|
Fermentation | 1 | 2005 | 143 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2010 | 1206 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5796 | 0.020 |
Why?
|
Paris | 1 | 2004 | 40 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11872 | 0.010 |
Why?
|
Drug Compounding | 1 | 2005 | 236 | 0.010 |
Why?
|
Hydrolysis | 1 | 2005 | 645 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.010 |
Why?
|
Muscles | 1 | 2009 | 1576 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3700 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3667 | 0.010 |
Why?
|
Cell Separation | 1 | 2010 | 1717 | 0.010 |
Why?
|
Hygiene | 1 | 2004 | 95 | 0.010 |
Why?
|
K562 Cells | 1 | 2005 | 644 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2006 | 0.010 |
Why?
|
Clostridium tetani | 1 | 2003 | 5 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6106 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1797 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4114 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1733 | 0.010 |
Why?
|
Administration, Rectal | 1 | 2003 | 69 | 0.010 |
Why?
|
Gene Silencing | 1 | 2010 | 1505 | 0.010 |
Why?
|
Rhodamine 123 | 1 | 2003 | 37 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2003 | 46 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9360 | 0.010 |
Why?
|
Tetanus | 1 | 2003 | 52 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2002 | 65 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 323 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2415 | 0.010 |
Why?
|
New York City | 1 | 2004 | 736 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6023 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1188 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2275 | 0.010 |
Why?
|
Ovalbumin | 1 | 2003 | 677 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5886 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 2168 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10815 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3642 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3468 | 0.010 |
Why?
|
NF-kappa B | 1 | 2008 | 2493 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9660 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1774 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2476 | 0.010 |
Why?
|
Capillaries | 1 | 2003 | 755 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 1176 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8504 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5891 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1331 | 0.010 |
Why?
|
Methotrexate | 1 | 2005 | 1718 | 0.010 |
Why?
|
Immunization | 1 | 2003 | 1218 | 0.010 |
Why?
|
Developed Countries | 1 | 2002 | 453 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11063 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2002 | 1472 | 0.010 |
Why?
|
Actins | 1 | 2005 | 2059 | 0.010 |
Why?
|
Paclitaxel | 1 | 2005 | 1728 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3317 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9513 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2009 | 3078 | 0.010 |
Why?
|
Research | 1 | 2004 | 1977 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1928 | 0.010 |
Why?
|
Lung | 1 | 2013 | 10076 | 0.010 |
Why?
|
Primary Prevention | 1 | 2002 | 1188 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2906 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14476 | 0.010 |
Why?
|
Health Promotion | 1 | 2004 | 2210 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5792 | 0.000 |
Why?
|